PartnerTech Signs Agreement with Biotage Worth SEK 90 Million

PartnerTech Signs Agreement with Biotage Worth SEK 90 Million Contract manufacturer PartnerTech has signed an agreement with biotech developer Biotage to become exclusive supplier of its new microwave synthesis system. The assignment, which includes both production and after-sales service, will boost PartnerTech's revenue by some SEK 90 million over three years. "This is the logical next step in our longstanding alliance with PartnerTech," says Biotage CEO Jeff Bork. "We worked closely with PartnerTech's development unit while designing the system," continues Bork. "Not only did that save time and money during the new product introduction phase, but it ensures an ongoing focus on improvement and cost effectiveness. We need a supplier who can take part in the development process and assume part of the responsibility for after-sales support. That leaves us more time for marketing activities and strengthening the leading position that we have already established." "Biotage has a dynamic approach to development and is an excellent partner that always challenges us to grow and evolve," says PartnerTech CEO Mikael Jonson. "That makes us stronger all the way around. We're very proud that Biotage has chosen us as exclusive manufacturer of this complex, high-tech system." Biotage is a market leader in the microwave synthesis stage of drug development. The new system is compact, flexible, user-friendly and cost-effective. Such qualities make it particularly attractive in individual microwave synthesis systems, an exciting new segment for Biotage. For additional information, please feel free to call: Mikael Jonson, CEO, PartnerTech AB: +46 70-678 10 01 Jeff Bork, President and CEO, Biotage AB: +46 734-22 16 60 As an international company in the field of life science research, Biotage has advanced technologies, wide-ranging operations and a long-term view of the market. Biotage provides solutions, expertise and experience in genetic analysis and medicinal chemistry. Its customers include the world's 30 largest pharmaceutical companies, 20 largest biotech firms and leading academic institutions. With its head office in Uppsala, Sweden, the company has branches in the United States, Japan and several countries of continental Europe. Biotage has some 235 employees, posted pro forma revenue of SEK 362 million in 2003 and is quoted on the Stockholm Stock Exchange. PartnerTech develops and manufactures products under contract for leading companies, primarily in telecommunications, IT, the engineering sector and medical technology. The company (www.partnertech.se), which has approximately 1,300 employees, reported revenue of more than SEK 1.3 billion in 2003 and is quoted on the O list of the Stockholm Stock Exchange. ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2004/11/09/20041109BIT20230/wkr0001.pdf In pdf